Tag:
Ventana
Latest Headlines
Latest Headlines
Ventana to work with Seattle Genetics, Millennium on companion Dx
The companion diagnostic trend continues--and Ventana Medical Systems is involved yet again. This morning, Seattle Genetics and Takeda's Millennium unit announced that they are working with the Roche company on a companion diagnostic test for use in a study involving Adcetris.
Siemens teams up with ViiV, Tocagen on companion Dx
Siemens ( $SI ) is taking a big step into the hot companion diagnostic arena. The company, which makes a wide range of products, has announced separate pacts with ViiV Healthcare and Tocagen related to
Ventana, Bayer to collaborate on companion Dx for cancer
Another week, another big personalized medicine partnership announcement from Ventana Medical Systems . This time, the Roche unit said it will be working with Bayer Pharma on a molecular companion
Ventana, Pfizer, CST collaborate on NSCLC companion diagnostic
In its latest of a series of companion diagnostic announcements, Roche's Ventana unit says it is collaborating with Pfizer ( $PFE ) and Cell Signaling Technology (CST) to develop a test identifying
Ventana inks separate companion Dx deals
Waltham, MA-based Syndax Pharmaceuticals is teaming up with Roche's Ventana Medical Systems to develop a companion diagnostic assay to select those non-small cell lung cancer patients who could
Roche CEO Schwan outlines drug/diagnostic acquisition strategy
Roche CEO Severin Schwan is in a deal-making mood, and he has some serious cash to gamble on new acquisitions that fit the pharma giant's overarching strategy for developing drugs that rely on a
Ventana, ACD ink co-promotion deal
Roche's Ventana unit and Advanced Cell Diagnostics have inked a co-promotion deal for the RNA in situ hybridization assay that permits the detection and visualization of almost any expressed gene in
Ventana wins clearance for H. pylori antibody
Roche's Ventana unit has garnered 510(k) clearance for its anti-H. pylori rabbit monoclonal primary antibody. It is the first H. pylori antibody to receive FDA clearance, and, when used in
Roche's Herceptin sensitivity test wins FDA nod
The FDA has approved a genetic test made by Roche's Ventana Medical Systems unit that more easily identifies ideal candidates for its breast cancer treatment Herceptin. Report
Roche announces 500 jobs, $180M expansion in AZ
Roche's Tucson, AZ, subsidiary, Ventana Medical Systems, has received the green light for a major expansion. The parent company announced a $180 million expansion to its current Oro Valley Campus,
